- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ , Pharmaceutical Technology - Pharma News and Development Insights. All rights reserved.
Featured Content
European Biotech Targeting Anti-ageing
Oct 2nd 2024
Novel mitophagy inducers and gene therapies that restore cellular function and decelerate the ageing process.
Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?
Mar 4th 2024
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Training for Operational Excellence
Dec 3rd 2023
The bio/pharmaceutical industry is struggling with the challenge of staffing and training.
Billions of Reasons to be Buoyant
Sep 2nd 2023
Pharma's ability to continually reinvent itself will be critical in growing future business operations.
Latest Videos
Latest News
Trenchant BioSystems Partners with Autolomous to Form Integrated Automated CGT Manufacturing Platform
January 24th 2025
The collaboration will combine fully automated and digitalized technologies to reduce CGT manufacturing timelines to 2.5 days.
Cytiva Collaborates with Cellular Origins to Deliver Automated Manufacturing for CGTs
January 22nd 2025
Cytiva will combine its CGT manufacturing technologies with Cellular Origins' robotic manufacturing platform.
Samsung Biologics Scores Major Manufacturing Deal Worth Over $1.4 Billion with European Pharma Company
January 17th 2025
Production is set to take place at Samsung Biologics’ Songdo, South Korea, site, and the agreement will run through December 2030, subject to change.
Lonza and Iconovo Team Up on Intranasal Biologic Candidate
January 15th 2025
Lonza will work with Iconovo to develop spray-dried formulations for an intranasally delivered biologic using a reformulated biologic drug candidate for obesity.
Behind the Headlines: 2024 Year in Review
January 8th 2025
Vanessa Almendro, Elliot Berger, Benjamin McCloud, and Turna Ray go behind the headlines to discuss 2024’s biggest trends in the pharmaceutical industry, as well as the unforeseen outcomes that took us by surprise.
Roche Forms Partnership Worth Potentially More than $1 Billion with Innovent to Develop Novel ADC for SCLC
January 3rd 2025
Under the agreement, the companies will advance development of IBI3009, Innovent’s ADC candidate, which has received IND approvals in the US, China, and Australia.
Orexo and Abera Partner to Develop Nasal Powder Vaccines
December 20th 2024
The companies will use Orexo’s powder-based drug delivery technology to develop mucosal vaccines in an inhaled formulation.
Scinai Immunotherapeutics Establishes US CDMO Business Unit
December 19th 2024
Scinai Bioservices Inc. has been established in Delaware as the company's new US-based subsidiary, which will serve biotech companies in early stage drug development.
AbbVie to Boost Immunology Pipeline with Acquisition of Nimble Therapeutics
December 18th 2024
AbbVie's latest acquisition target is Nimble Therapeutics, which will give AbbVie a lead asset, an oral peptide for treating psoriasis.
Intertek Teams Up with CrystecPharma on Formulation and Development of Dry Powder Inhaler Products
December 13th 2024
The partners will aim to establish a platform that enables rapid development of DPI products.